FULL-TEXT ARTICLE
The cost-effectiveness of oral HIV pre-exposure
prophylaxis and early antiretroviral therapy in the presence of
drug resistance among men who have sex with men in San
Francisco.
Shen M, Xiao Y, Rong L, et al
BMC Med.
2018 Apr 24;16(1):58.
Paper
Impact
of Improved HIV Care and Treatment on PrEP Effectiveness in the
United States, 2016-2020.
Khurana N, Yaylali E, Farnham PG,
J Acquir
Immune Defic Syndr.
2018 Apr 20.
Abstract
HIV Preexposure Prophylaxis: A Review.
Riddell J 4th, Amico KR, Mayer KH.
JAMA.
2018 Mar 27;319(12):1261-1268
Abstract
Skating on thin ice: stimulant use and sub-optimal adherence to
HIV pre-exposure prophylaxis.
Hojilla JC, Vlahov D, Glidden DV,
et a;
J Int AIDS Soc.
2018 Mar;21(3):e25103.
Abstract
A Mobile Health Strategy to Support Adherence to Antiretroviral
Preexposure Prophylaxis.
Fuchs JD, Stojanovski K, Vittinghoff E, et al
AIDS
Patient Care STDS.
2018 Mar;32(3):104-111.
Abstract
Correlates of Linkage to HIV Preexposure Prophylaxis Among HIV-Testing
Clients.
Flash CA, Adegboyega OO, Yu X,
J Acquir Immune Defic Syndr. 2018 Apr
1;77(4):365-372.
Abstract
PrEP Initiation and Retention in care over five years,
2012-2017: Are quarterly visits too much?
Rusie LK, Orengo C, Burrell D,
Clin
Infect Dis. 2018
Mar 1.
Abstract
Pre-Exposure Prophylaxis YouTube Videos: Content Evaluation.
Kecojevic A, Basch C, Basch C, Kernan W.
JMIR Public Health Surveill.
2018 Feb 16;4(1):e19
Abstract
Retention, engagement, and adherence to pre-exposure prophylaxis for men who
have sex with men and transgender women in PrEP Brasil: 48 week results of a
demonstration study.
Grinsztejn B, Hoagland B, Moreira RI,
wt al
Lancet HIV. 2018 Feb 16
Abstract
PrEP Stigma: Implicit and Explicit Drivers of Disparity
Golub SA.
Curr HIV/AIDS Rep. 2018 Feb
Abstract
Syndemics among individuals enrolled in the PrEP Brasil
Study.
De Boni RB, Machado IK, De Vasconcellos MTL, et al
Drug Alcohol Depend.
2018 Feb 10;185:168-172.
Abstract
Pre-exposure prophylaxis for HIV prevention in East and Southern Africa.
Van der Wal R, Loutfi D.
Can J Public Health. 2018 Jan
22;
Abstract
Temporal Fluctuations in Behavior, Perceived HIV Risk, and
Willingness to Use Pre-Exposure Prophylaxis (PrEP).
Underhill K, Guthrie KM, Colleran C,
Arch Sex Behav. 2018 Jan 11.
Abstract
Who Starts the Conversation and Who Receives Preexposure Prophylaxis
(PrEP)?: A Brief Online Survey of Medical Providers' PrEP Practices.
Adams LM, Balderson BH, Brown K
Health
Educ Behav. 2018 Jan
1:1090198117752789
Abstract
Facilitators and
Barriers to Pre-Exposure
Prophylaxis Willingness Among
Young Men Who Have Sex with Men
Who Use Geosocial Networking
Applications in California.
Holloway IW, Tan D, Gildner JL,
et al
AIDS Patient Care STDS.
2017 Dec;31(12):517-527.
Abstract
Can we afford to offer pre-exposure prophylaxis to MSM in
Catalonia? Cost-effectiveness analysis and budget impact assessment.
Reyes-Urueña J, Campbell C, Diez E,et al
AIDS Care. 2017 Dec 20:1-9.
Abstract
HIV Care Providers' Intentions to Prescribe and Actual
Prescription of Pre-Exposure Prophylaxis to At-Risk Adolescents and Adults.
Mullins TLK, Zimet G, Lally M, Xu J, Thornton S, Kahn JA.
AIDS Patient Care STDS.
2017 Dec;31(12):504-516.
Abstract
Body/Selves and Beyond: Men's Narratives of Sexual Behavior
on PrEP.
Hughes SD, Sheon N, Andrew EVW,
et al
Med Anthropol.
2017 Dec 19.
Abstract
Evaluation of the Southern Harm Reduction Coalition for HIV Prevention:
Advocacy Accomplishments.
Story CR; , Kao WK, Currin J, et al
Health Promot Pract. 2017
Nov 1:
Abstract
FULL-TEXT ARTICLE
Awareness, discussion and non-prescribed use of HIV pre-exposure prophylaxis
among persons living with HIV/AIDS in Italy: a Nationwide, cross-sectional
study among patients on antiretrovirals and their treating HIV physicians.
Palummieri A, De Carli G, Rosenthal
É, et al
BMC
Infect Dis. 2017 Nov 28;17(1):734
Paper
FULL-TEXT ARTICLE
Canadian guideline on HIV
pre-exposure prophylaxis and nonoccupational postexposure prophylaxis.
Tan DHS, Hull MW, Yoong D, et al
CMAJ. 2017 Nov
27;189(47):E1448-E1458.
Paper
Evolving models and ongoing challenges for HIV pre-exposure prophylaxis
implementation in the United States.
Mayer KH, Chan PA, Patel R,
et al
J Acquir Immune Defic Syndr.
2017 Oct 27.
Abstract
Integrating HIV Preexposure Prophylaxis (PrEP) Into Routine
Preventive Health Care to Avoid Exacerbating Disparities.
Calabrese SK, Krakower DS, Mayer KH.
Am J Public Health.
2017 Oct 19:e1-e7
Abstract
HIV pre-exposure prophylaxis implementation at local health
departments: a statewide assessment of activities and barriers.
Zhang HL, Rhea SK, Hurt CB,
et al
J Acquir Immune Defic Syndr. 2017
Sep 11.
Abstract
Examining the Impact of Intimate Partner Violence Type and Timing on
Pre-exposure Prophylaxis Awareness, Interest, and Coercion.
Willie TC, Stockman JK, Overstreet NM, Kershaw TS.
AIDS Behav. 2
Abstract
Developing a Web-Based Geolocated Directory of HIV
Pre-Exposure Prophylaxis-Providing Clinics: The PrEP Locator
Protocol and Operating Procedures.
Siegler AJ, Wirtz S, Weber S, Sullivan
PS.
JMIR Public Health Surveill. 2017 Sep 6;3(3):e58.
Abstract
Barriers to Access and Adoption of Pre-Exposure
Prophylaxis for the Prevention of HIV Among Men Who Have Sex
With Men (MSM) in a Relatively Rural State.
Hubach RD, Currin JM, Sanders CA, et al;
AIDS Educ Prev. 2017 Aug;29
Abstract
Estimated coverage to address financial barriers to HIV
preexposure prophylaxis among persons with indications for its
use, United States, 2015.
Smith DK, Van Handel M, Huggins R.
J Acquir Immune Defic Syndr.
2017 Aug 22.
Abstract
Alignment of adherence and risk for HIV acquisition in a
demonstration project of pre-exposure prophylaxis among HIV
serodiscordant couples in Kenya and Uganda: a prospective
analysis of prevention-effective adherence.
Haberer JE, Kidoguchi L, Heffron R, et al
J Int AIDS Soc.
2017 Jul 25;20(1):1-
Abstract
Experiences Using Pre-Exposure Prophylaxis for Safer Conception
Among HIV Serodiscordant Heterosexual Couples in the United
States.
Bazzi AR, Leech AA, Biancarelli DL,
et
al
AIDS
Patient Care STDS.
2017 Jul 18.
Abstract
Measuring Acceptability and Preferences for Implementation of
Pre-Exposure Prophylaxis (PrEP) Using Conjoint Analysis: An
Application to Primary HIV Prevention Among High Risk Drug
Users.
Shrestha R, Karki P, Altice FL,
et al
AIDS Behav. 2017 Jul 10.
Abstract
Differences in Awareness of Pre-exposure Prophylaxis and
Post-exposure Prophylaxis Among Groups At-Risk for HIV in New
York State: New York City and Long Island, NY, 2011-2013.
Walters SM, Rivera AV, Starbuck L, Reilly KH,
J
Acquir Immune Defic Syndr.
2017 Jul 1;75 Suppl 3:S383-S391
Abstract
Differences in Awareness of Pre-exposure Prophylaxis and
Post-exposure Prophylaxis Among Groups At-Risk for HIV in New
York State: New York City and Long Island, NY, 2011-2013.
Walters SM, Rivera AV, Starbuck L, Reilly KH,
J
Acquir Immune Defic Syndr.
2017 Jul 1;75 Suppl 3:S383-S391
Abstract
HIV preexposure prophylaxis for adolescents and young adults.
Allen E, Gordon A, Krakower D, Hsu K.
Curr
Opin Pediatr.
2017 Jun 8
Abstract
FULL-TEXT
ARTICLE
Impact
of insurance coverage on utilization of pre-exposure prophylaxis
for HIV prevention
Patel RR, Mena L, Nunn A
PLoS One.
2017 May 30;12(5):e0178737.
Paper
Assessing the
need for a pre-exposure
prophylaxis programme using the
social media app Grindr®.
Hampel B, Kusejko K, Braun DL
HIV Med. 2017 May 19
Abstract
The Potential Cost-Effectiveness of Pre-Exposure
Prophylaxis Combined with HIV Vaccines in the United
States.
Adamson BJS, Carlson JJ, Kublin JG, Garrison LP.
Vaccines (Basel).
2017 May 24;5(2).
Abstract
Medication adherence, condom use and sexually transmitted
infections in Australian PrEP users: interim results from the
Victorian PrEP Demonstration Project.
al L, Audsley J, Murphy D, Fairley CK, et al
AIDS. 2017 May 1.
Abstract
Blood safety implications of donors using HIV
pre-exposure prophylaxis.
Seed CR, Yang H, Lee JF.
Vox Sang. 2017 Mar 31
Abstract
A novel Online-to-Offline (O2O) model for
pre-exposure prophylaxis and HIV testing scale up.
Anand T, Nitpolprasert C, Trachunthong D, et al
J Int AIDS Soc.
2017 Mar 10;20(1):1-11.
Abstract
FULL-TEXT
ARTICLE
Awareness and attitudes of pre-exposure prophylaxis for HIV
prevention among physicians in Guatemala: Implications for
country-wide implementation.
Ross I, Mejia C, Melendez J, Chan PA, et al;
PLoS One. 2017 Mar
3;12(3):e0173057.
Paper
FULL-TEXT ARTICLE
Social, structural, behavioral and clinical factors influencing
retention in Pre-Exposure Prophylaxis (PrEP) care in
Mississippi.
Arnold T, Brinkley-Rubinstein L, et al
PLoS One. 2017 Feb
21;12(2):e0172354
Paper
Executive summary: Pre-exposure prophylaxis for prevention of
HIV infection in adults in Spain: July 2016.
Moreno S, Antela A, García F, Del Amo J, et al
Enferm Infecc Microbiol Clin.
2017 Feb 21.
Abstract
Reaching Key Populations: PrEP
Uptake in an Urban Health Care System in the Bronx, New York.
Bien CH, Patel VV, Blackstock OJ, Felsen UR.
AIDS Behav. 2016 Dec 26.
Abstract
PrEP Awareness, Familiarity, Comfort, and Prescribing Experience
among US Primary Care Providers and HIV Specialists.
Petroll AE, Walsh JL, Owczarzak JL, et al
AIDS Behav. 2016 Nov 24.
Abstract
Occurrence of HIV eradication for preexposure prophylaxis
treatment with a deterministic HIV model.
Chang H, Moog C,
Astolfi A.|IET
Syst Biol. 2016 Dec;10(6):237-243.
Abstract
Where next with preexposure prophylaxis?
Nugent D, Gilson R. |
Curr Opin Infect Dis.
2016 Nov 18..
Abstract
Preexposure Prophylaxis for HIV Prevention in a Large Integrated
Health Care System: Adherence, Renal Safety, and
Discontinuation.
Marcus JL, Hurley LB, Hare CB, Nguyen DP,
J Acquir Immune Defic Syndr.
2016 Dec 15;73(5):540-546..
Abstract
A Preemptive Weapon.
Berlin J.
Tex Med.
2016 Nov 1;112(11):39-44.
Abstract
A Cross-Sectional Online Survey of HIV Pre-Exposure Prophylaxis
Adoption Among Primary Care Physicians.
Blackstock OJ, Moore BA, Berkenblit GV,
et al
J Gen Intern Med. 2016
Oct 24.
Abstract
Cost-effectiveness analysis of pre-exposure
prophylaxis for HIV-1 prevention in the Netherlands: a
mathematical modelling study.
Nichols BE, Boucher CA, van der Valk M,
et al
Lancet Infect Dis.
2016 Sep 22.
Abstract
Informing Strategies to Build PrEP Capacity among
San Francisco Bay Area Clinicians.
Bacon O, Gonzalez R, Andrew E,
et al
J Acquir Immune Defic Syndr.
2016 Sep 19
Abstract
Pre-exposure prophylaxis: a useful tool to prevent human
immunodeficiency virus infection?
Pialoux G, Delaugerre C, Cotte L,
et al
Clin Microbiol Infect.
2016 Sep 8
Abstract
Impact of circulating resistance-associated mutations on HIV
pre-exposure prophylaxis (PrEP) efficacy: Modeling from antiretroviral
resistance cohort analysis (ARCA) national database.
Rossotti R, Borghi V, Callegaro AP,
et al
J Clin Virol.
2016 Aug 23;83:48-53..
Abstract
HIV-1-neutralizing IgA is detected in genital secretions of
highly HIV-1 exposed seronegative women on oral pre-exposure prophylaxis.
Lund JM, Broliden K, Pyra MN, Thomas KK, et al
J Virol. 2016 Aug 24.
Abstract
HIV pre-exposure prophylaxis for women and infants prevents
vaginal and oral HIV transmission in a preclinical model of HIV infection.
Kovarova M, Shanmugasundaram U, Baker CE, et al
J Antimicrob Chemother. 2016 Aug 1.
Abstract
To whom is HIV pre-exposure prophylaxis proposed?
Ayerdi-Aguirrebengoa O, Vera-García M, Puerta-López T,
et al
Enferm Infecc Microbiol Clin. 2016
Jul 18.
Abstract
FULL-TEXT ARTICLE
Adherence to Pre-Exposure Prophylaxis for HIV Prevention in a Clinical
Setting.
Montgomery MC, Oldenburg CE, Nunn AS,
et al
PLoS
One. 2016 Jun
22;11(6):e01577
Paper
The Potential of Pre-Exposure Prophylaxis for Women in
Violent Relationships.
Braksmajer A, Senn TE, McMahon J.
AIDS Patient Care STDS. 2016
Jun;30(6):274-81
Abstract
FULL-TEXT ARTICLE
PrEP Awareness and Attitudes in a National Survey of Primary Care Clinicians in
the United States, 2009-2015.
Smith DK, Mendoza MC, Stryker JE, Rose CE.
PLoS One. 2016 Jun
3;11(6):e0156592.
Paper
FULl-TEXT ARTICLE
Pre-exposure prophylaxis
for the prevention of HIV infection: a new prevention paradigm?
Sánchez-Rubio Ferrández J, Martínez Sesmero JM.
Farm Hosp.
2016 May 1;40(n03):219-2
Paper
Attitudes Toward HIV Pre-Exposure Prophylaxis in
a United States Urban Clinic Population.
Kwakwa HA, Bessias S, Sturgis D,
et
al
AIDS Behav.
2016 Apr 26.
Abstract
PrEP as Peri-conception HIV
Prevention for Women and Men.
Heffron R, Pintye J, Matthews LT, et al
Curr HIV/AIDS Rep. 2016 Mar 18.
Abstract
'HIV
providers' likelihood to prescribe pre-exposure
prophylaxis (PrEP) for HIV prevention differs by
patient type: a short report.
Adams
LM, Balderson BH.
AIDS Care.
2016 Feb 26:1-5
Abstract
Successful Implementation of HIV
Preexposure Prophylaxis: Lessons Learned From
Three Clinical Settings
Marcus JL, Volk JE, Pinder J,
et al
Curr HIV/AIDS Rep.
2016 Feb 22.
Abstract
Framing HIV Pre-Exposure Prophylaxis (PrEP) for the General Public: How
Inclusive Messaging May Prevent Prejudice from Diminishing Public Support.
Calabrese SK, Underhill K, Earnshaw VA,
et al
AIDS Behav. 2016 Feb 19.
Abstract
FULL-TEXT ARTICLE
Knowledge, Attitudes, and Acceptability of Pre-Exposure Prophylaxis among
Individuals Living with HIV in an Urban HIV Clinic.
Jayakumaran JS, Aaron E, Gracely EJ, et
al
PLoS One.
2016 Feb 10;11(2):e0145670.
Paper
Preexposure Prophylaxis (PrEP) for HIV Prevention: The Primary Care
Perspective.
Conniff J, Evensen A.
J Am Board Fam Med.
2016 Jan-Feb;29(1):143-51..
Abstract
Improving outpatient implementation of preexposure
prophylaxis in men who have sex with men.
Scholl E.
J Am Assoc Nurse Pract. 2016 Jan 27
Abstract
FULL-TEXT ARTICLE
Complex and Conflicting Social Norms: Implications for Implementation of Future
HIV Pre-Exposure Prophylaxis (PrEP) Interventions in Vancouver, Canada.
Knight R, Small W, Carson A, Shoveller J.
PLoS One. 2016 Jan
12;11(1):e0146513.
Paper
Preexposure prophylaxis-selected drug resistance decays rapidly after drug
cessation.
Weis JF, Baeten JM, McCoy CO, et al
AIDS. 2016 Jan
2;30(1):31-35.
Abstract
FULL-TEXT ARTICLE
Assessment of Oral Fluid HIV Test Performance in an HIV Pre-Exposure Prophylaxis
Trial in Bangkok, Thailand.
Suntharasamai P, Martin M, Choopanya K, et al
PLoS One. 2015 Dec
30;10(12):e0145859.
Paper
Nondaily preexposure prophylaxis for HIV prevention.
Anderson PL, García-Lerma JG, Heneine W.
Curr Opin HIV AIDS. 2016 Jan;11(1):94-101.
Abstract
FULL-TEXT ARTICLE
Vital Signs:
Increased Medicaid Prescriptions for Preexposure Prophylaxis Against HIV
infection - New York, 2012-2015.
Laufer FN, O'Connell DA, Feldman I; MPS, Zucker HA.
MMWR Morb Mortal Wkly Rep.
2015 Nov 27;64(46)
Paper
The preexposure prophylaxis revolution: from clinical trials to
routine practice: implementation view from the USA.
Elion R, Coleman M.
Curr Opin HIV AIDS. 2015 Nov 23.
Abstract
The European preexposure prophylaxis revolution.
Cairns G, McCormack S, Molina JM.
Curr Opin HIV AIDS. 2015
Nov 23.
Abstract
What people want from sex and preexposure prophylaxis.
Grant RM, Koester KA.
Curr Opin HIV AIDS. 2015 Nov 13
Abstract
What do we know about the cost-effectiveness of HIV preexposure prophylaxis, and
is it affordable?
Cambiano V, Miners A, Phillips A.
Curr Opin HIV AIDS. 2015 Nov 13
Abstract
Preexposure Prophylaxis for HIV Infection Integrated With
Municipal- and Community-Based Sexual Health Services.
Liu AY, Cohen SE, Vittinghoff E, et al
JAMA Intern Med. 2015 Nov 16
Abstract
What does preexposure prophylaxis mean for treatment; what does treatment mean
for preexposure prophylaxis?
Venter WD.
Curr Opin HIV AIDS. 2015 Nov 5.
Abstract
Statistical issues in trials of preexposure prophylaxis.
Dunn DT, Glidden DV.
Curr Opin HIV AIDS. 2015
Nov 5.
Abstract
The role of healthcare providers in the roll out of preexposure
prophylaxis.
Krakower DS, Mayer KH.
Curr Opin HIV AIDS. 2015 Sep 28
Abstract
Consensus Document on post-exposure prophylaxis against HIV, HBV and HCV in
adults and children
Grupo de expertos de la Secretaría del
Plan Nacional sobre el Sida (SPNS); Grupo de Estudio de Sida (GeSIDA); Sociedad
Española de Medicina y Seguridad del Trabajo (SEMST); Grupo de Estudio de Sida (GeSIDA);
Sociedad Española de Medicina y Seguridad del Trabajo (SEMST); Sociedad Española
de Medicina Preventiva;
et al
Enferm Infecc Microbiol Clin. 2015 Sep 22
Abstract
FULL-TEXT ARTICLE
Pre-exposure prophylaxis to prevent the acquisition
of HIV-1 infection (PROUD): effectiveness results
from the pilot phase of a pragmatic open-label
randomised trial.
McCormack S, Dunn DT, Desai M, et al
Lancet.
2015 Sep 9.
Paper
|
Acceptability of HIV Pre-Exposure Prophylaxis (PrEP) and
Implementation Challenges Among Men Who Have Sex with Men in India: A
Qualitative Investigation.
Chakrapani V, Newman PA, Shunmugam M,
et al
AIDS Patient Care STDS. 2015 Sep
8.
Abstract
No New HIV Infections with Increasing Use of HIV Preexposure Prophylaxis in
a Clinical Practice Setting.
Volk JE, Marcus JL, Phengrasamy T, et al
Clin Infect Dis. 2015 Sep 1.
Abstract
FULL-TEXT ARTICLE
PrEP Implementation Science: State-of-the-Art
and Research Agenda.
Cáceres CF, Mayer KH, Baggaley R, O'Reilly KR.
J Int AIDS Soc.
2015 Jul 20;
Paper
FULL-TEXT ARTICLE
PrEP implementation: moving from trials to
policy and practice.
Cáceres CF, O'Reilly KR, Mayer KH, Baggaley R.
J Int AIDS Soc.
2015 Jul 20;18(4(Suppl 3)):20222.
Paper
FULL-TEXT ARTICLE
Beyond "getting drugs into bodies": social
science perspectives on pre-exposure prophylaxis
for HIV
Auerbach JD, Hoppe TA.
J Int AIDS Soc.
2015 Jul 20;18(4(Suppl 3)):19983.
Paper
FULL-TEXT ARTICLE
Translating PrEP effectiveness into public
health impact: key considerations for
decision-makers on cost-effectiveness, price,
regulatory issues, distributive justice and
advocacy for access
Hankins C, Macklin R, Warren M.
J Int AIDS Soc.
2015 Jul 20;18(4(Suppl 3)):19973.
Paper
FULL-TEXT ARTICLE
Antiretroviral pre-exposure prophylaxis
implementation in the United States: a work in
progress.
Mayer KH, Hosek S, Cohen S,
et al
J Int AIDS Soc.
2015 Jul 20;18(4(Suppl 3)):19980
Paper
FULL-TEXT ARTICLE
The promises and challenges of pre-exposure
prophylaxis as part of the emerging paradigm of
combination HIV prevention.
Cáceres CF, Koechlin F, Goicochea P,
et al
J Int AIDS Soc.
2015 Jul 20;18(4(Suppl 3)):19949.
Paper
FULL-TEXT ARTICLE
Pre-exposure prophylaxis in Southern Africa:
feasible or not?
Venter WD, Cowan F, Black V,
et al|
J Int AIDS Soc.
2015 Jul 20;18(4(Suppl 3)):19979.
Paper
FULL-TEXT ARTICLE
Seasonal PrEP for partners of migrant miners in
southern Mozambique: a highly focused PrEP
intervention.
Cremin I, Morales F, Jewell BL,
et al
J Int AIDS Soc. 2015 Jul
20;18(4(Suppl 3)):19946
Paper
Demographic Differences in PrEP-Related
Stereotypes: Implications for Implementation.
Golub SA, Gamarel KE, Surace A.
AIDS Behav.
2015 Jul 5.
Abstract
Cellular immune correlates
analysis of an HIV-1 preexposure prophylaxis
trial.
Kuebler PJ, Mehrotra ML, McConnell JJ, et
al
Proc Natl Acad Sci U S A.
2015 Jun 22.
Abstract
The Transition From Postexposure Prophylaxis to Preexposure
Prophylaxis: An Emerging Opportunity for Biobehavioral HIV
Prevention.
Jain S, Krakower DS, Mayer KH
Clin Infect Dis.
2015 Jun 1;60 Suppl 3:S200-4.
Abstract
Clinical Treatment Options
Infectious Diseases: Update on PrEP
Implementation, Adherence, and Advances in
Delivery.
Doblecki-Lewis S, Cohen S, Liu A.
Curr Treat Options Infect Dis.
2015 Jun;7(2):101-112.
Abstract
Optimizing adherence to preexposure and
postexposure prophylaxis: the need for an
integrated biobehavioral approach.
Blashill AJ, Ehlinger PP, Mayer KH, Safren SA.
Clin Infect Dis.
2015 Jun 1;60 Suppl 3:S187-90.
Abstract
Estimating the range of potential epidemiological impact of pre-exposure
prophylaxis: run-away success or run-away failure?
Cremin Í, Hallett TB.
AIDS. 2015 Mar
27;29(6):733-738.
Abstract
Pre-Exposure Prophylaxis to Prevent HIV Infection: Current
Status, Future Opportunities and Challenges.
Krakower DS, Mayer KH.
Drugs. 2015 Feb 12
Abstract
Turning the tide against AIDS by preventing new HIV
infections initial experience with Minnesota's first PrEP clinic.
Eccles-Radtke C, Henry K
Minn
Med. 2015 Jan;98(1):45-8.
Abstract
Evaluating the impact of prioritization of antiretroviral
pre-exposure prophylaxis in New York.
Kessler J, Myers JE, Nucifora KA, et al
AIDS. 2014 Nov
28;28(18):2683-2691.
Abstract
Pre-exposure Prophylaxis for Human Immunodeficiency Virus: The Past,
Present, and Future.
Castel AD, Magnus M, Greenberg AE.
Infect Dis Clin North Am.
2014 Dec;28(4):563-583
Abstract
Using geospatial modelling to optimize the rollout of
antiretroviral-based pre-exposure HIV interventions in Sub-Saharan Africa.
Gerberry DJ, Wagner BG, Garcia-Lerma JG, et al
Nat Commun. 2014 Dec 2;5:5454.
Abstract
Oral preexposure prophylaxis to prevent HIV infection:
Clinical and public health implications.
Baker J, OʼHara KM.
JAAPA. 2014 Nov 11
Abstract
Streamlining HIV testing for HIV Pre-exposure Prophylaxis.
Guanira JV, Leigler T, Kallas E, et al
J Clin Microbiol. 2014
Nov 5.
Abstract
FULL-TEXT
PDF ARTICLE
HIV
Preexposure Prophylaxis in the Real World
Daskalakis DC.
Top Antivir Med.
2014 September/October;22(4):670-675
Paper
Exploratory survey of Florida pharmacists' experience,
knowledge, and perception of HIV pre-exposure prophylaxis.
Shaeer KM, Sherman EM, Shafiq S, Hardigan P.
J Am Pharm Assoc (2003). 2014 Oct
24:e380-e387
Abstract
Role of Oral Pre-exposure Prophylaxis (PrEP) in Current and Future HIV
Prevention Strategies.
Burns DN, Grossman C, Turpin J, et al
Curr HIV/AIDS Rep. 2014 Oct 5
Abstract
Comparing the Novel Method of Assessing PrEP Adherence/Exposure using Hair
Samples to other Pharmacologic and Traditional Measures
Baxi SM, Liu A, Bacchetti P, et al
J Acquir Immune Defic Syndr. 2014
Oct 7.
Abstract
Non-occupational Post-exposure Prophylaxis for HIV in New York State Emergency
Departments.
Fitzpatrick LJ, Egan DJ, Cowan E,
J Int Assoc Provid AIDS Care.
2014 Oct 7
Abstract
Configuring the users of new HIV-prevention technologies: the case of HIV
pre-exposure prophylaxis.
Holt M.
Cult Health Sex. 2014 Oct 1:1-12
Abstract
Preexposure prophylaxis: An emerging clinical approach to preventing HIV in
high-risk adults.
Blackwell CW.
Nurse Pract. 2014 Sep
18;39(9):50-53.
Abstract
Evaluating the impact of prioritization of antiretroviral
pre-exposure prophylaxis in New York City.
Kessler J, Myers JE, Nucifora KA,
et aj
AIDS. 2014 Sep 10
Abstract
FULL-TEXT ARTICLE
Preparing for PrEP: Perceptions and Readiness of Canadian Physicians for the
Implementation of HIV Pre-Exposure Prophylaxis.
Sharma M, Wilton J, Senn H, et al
PLoS One. 2014 Aug 18;9(8):e105283.
Paper
Pre-exposure prophylaxis of HIV: A right way to go or a long way to go?
Yu W, Wang L, Han N, et al
Artif Cells Nanomed Biotechnol.
2014 Jul 31:1-8.
Abstract
Pre-Exposure Prophylaxis Accessibility Research and Evaluation (PrEPARE
Study).
King HL, Keller SB, Giancola MA, et al
AIDS Behav. 2014 Jul 14
Abstract
Adherence to preexposure prophylaxis: current, emerging, and
anticipated bases of evidence.
Amico KR, Stirratt MJ.
Clin Infect Dis. 2014 Jul 1;59 Suppl
1:S55-60
Abstract
Pharmacology lessons from chemoprophylaxis studies.
Boffito M, Jackson A, Asboe D.
Clin Infect Dis. 2014 Jul
1;59 Suppl 1:S52-4.
Abstract
Biomedical prevention: state of the science.
McCormack SM, Gafos M, et al
Clin Infect Dis. 2014 Jul 1;59
Suppl 1:S41-6
Abstract
Antiretroviral chemoprophylaxis: state of evidence and the research agenda.
Mayer KH.
Clin Infect Dis. 2014 Jul
1;59 Suppl 1:S47-51.
Abstract
Successful Discontinuation of the Placebo Arm and Provision of an Effective HIV
Prevention Product After a Positive Interim Efficacy Result:
The Partners PrEP
Study Experience.
Ndase P, Celum C, Campbell J, et al
J Acquir Immune Defic Syndr. 2014 Jun
1;66(2):206-12
Abstract
FULL-TEXT ARTICLE
Normal Laboratory Reference Intervals among Healthy Adults Screened for a
HIV Pre-Exposure Prophylaxis Clinical Trial in Botswana.
Segolodi TM, Henderson FL, Rose CE, et al
PLoS One. 2014 Apr
8;9(4):e93034.
Paper
Suboptimal awareness and comprehension of published
preexposure prophylaxis efficacy results among physicians in Massachusetts.
Mimiaga MJ, White JM, Krakower DS, et al
AIDS Care. 2014 Jun;26(6):684-93.
Abstract
A Cost-effectiveness Analysis of HIV Preexposure Prophylaxis
for Men Who Have Sex With Men in Australia.
Schneider K, Gray RT, Wilson DP.
Clin Infect Dis. 2014 Apr;58(7):1027-34.
Abstract
An Overview of Antiretroviral Pre-Exposure Prophylaxis of
HIV Infection.
McGowan I.
Am J Reprod Immunol.
2014 Mar 17.
Abstract
FULL-TEXT ARTICLE
Early Experiences Implementing Pre-exposure Prophylaxis (PrEP) for HIV
Prevention in San Francisco.
Liu A, Cohen S, Follansbee S, et al
PLoS Med.
2014 Mar 4;11(3):e1001613.
Paper
Helping our patients take HIV pre-exposure prophylaxis (PrEP): a
systematic review of adherence interventions.
Marcus J, Buisker T, Horvath T, et al
HIV Med. 2014 Feb 24.
Abstract
Pre-exposure prophylaxis for conception (PrEP-C) as a risk reduction strategy in
HIV-positive men and HIV-negative women in the UK.
Whetham J, Taylor S, Charlwood L,
et al
AIDS Care. 2014
Mar;26(3):332-6.
Abstract
Preexposure prophylaxis (PrEP) of HIV infection in France: A
nationwide cross-sectional study (PREVIC study).
Rosenthal E, Piroth L, Cua E, et al
AIDS Care. 2014 Feb;26(2):176-85
Abstract
Untangling the cost-effectiveness knot: who is oral
antiretroviral HIV pre-exposure prophylaxis really for?
Hankins CA.
Expert Rev Pharmacoecon Outcomes Res.
2014 Feb 19.
Abstract
FULL-TEXT ARTICLE
Pre-Exposure Prophylaxis for the Prevention of HIV Infection in High Risk
Populations: A Meta-Analysis of Randomized Controlled Trials.
Jiang J, Yang X, Ye L, Zhou B, et al
PLoS One. 2014 Feb
3;9(2):e87674
Paper
Systemic Preexposure Prophylaxis for HIV: Translating Clinical Data to Clinical
Practice.
Li J, Dufrene SL, Okulicz JF.
Ann Pharmacother. 2014 Jan 28
Abstract
The Impact of Patient Race on Clinical Decisions Related to Prescribing HIV
Pre-Exposure Prophylaxis (PrEP): Assumptions About Sexual Risk Compensation and
Implications for Access.
Calabrese SK, Earnshaw VA, Underhill K, et al
AIDS Behav. 2013 Dec 24.
Abstract
FULL-TEXT
ARTICLE
No Evidence of Sexual Risk Compensation in the iPrEx Trial of Daily Oral
HIV Preexposure Prophylaxis.
Marcus JL, Glidden DV, Mayer KH, et al
PLoS One.
2013 Dec 18;8(12):e81997.
Paper
Provider Attitudes toward Oral Pre-Exposure Prophylaxis for HIV
Prevention among High-Risk MSM in Lima, Peru.
Tang EC, Sobieszczyk ME, Shu E,
et al
AIDS Res Hum Retroviruses. 2013 Dec 10
Abstract
FULL-TEXT ARTICLE
Analytic Review of Modeling Studies of ARV Based PrEP Interventions Reveals
Strong Influence of Drug-Resistance Assumptions on the Population-Level
Effectiveness
Dimitrov D, Boily MC, Brown ER, Hallett TB.
PLoS One. 2013 Nov
25;8(11):e80927.
Paper
The development of rectal microbicides for HIV prevention.
McGowan I.
Expert Opin Drug Deliv. 2013 Nov 25
Abstract
Assessing the Cost Effectiveness of Pre-Exposure Prophylaxis
for HIV Prevention in the US.
Hellinger FJ.
Pharmacoeconomics. 2013 Nov 24.
Abstract
Rectal pre-exposure prophylaxis (PrEP).
Rohan LC, Yang H, Wang L.
Antiviral Res. 2013 Oct 24.
Abstract
FULL-TEXT PDF ARTICLE
Challenges and opportunities for oral pre-exposure prophylaxis in the
prevention of HIV infection: where are we in Europe?
Molina JM, Pintado C, Gatey C, et al
BMC Med. 2013 Aug 23;11(1):186
Paper
Pre-exposure prophylaxis for conception (PrEP-C) as a risk
reduction strategy in HIV-positive men and HIV-negative women in the UK.
Whetham J, Taylor S, Charlwood L, et al
AIDS Care. 2013 Jul 22.
Abstract
Study design considerations for evaluating efficacy of systemic
preexposure prophylaxis interventions.
Donnell D, Hughes JP, Wang L, et al
J Acquir Immune Defic Syndr.
2013 Jul;63 Suppl 2:S130-4.
Abstract
Preexposure Prophylaxis for HIV Prevention: Where Have We Been and Where Are We
Going?
Baeten JM, Haberer JE, Liu AY, Sista N.
J Acquir Immune Defic Syndr.
2013 Jul;63 Suppl 2:S122-9.
Abstract
Preexposureprophylaxis (PrEP) of HIV infection in France: A
nationwide cross-sectional study (PREVIC study).
Rosenthal E, Piroth L, Cua E, Joulié A, et al
AIDS Care. 2013 Jun 11
Abstract
Knowledge of and opinions on HIV pre-exposure prophylaxis among
front-line service providers at Canadian AIDS Service Organizations.
Senn H, Wilton J, Sharma M,
et al
AIDS Res Hum Retroviruses. 2013 Jun 3
Abstract
Daily Short Message Service Surveys to Measure Sexual Behavior
and Pre-exposure Prophylaxis Use Among Kenyan Men and Women.
Curran K, Mugo NR, Kurth A, et
al
AIDS Behav. 2013 May 22.
Abstract
Racial differences and correlates of potential adoption of
preexposure prophylaxis: results of a national survey.
Wingood GM, Dunkle K, Camp C,
et al
J Acquir Immune Defic Syndr. 2013
Jun;63 Suppl 1:S95-S101
Abstract
FULL-TEXT PDF ARTICLE
Attitude
towards antiretroviral pre-exposure prophylaxis (PrEP) prescription among HIV
specialists.
Puro V, Palummieri A, De Carli G, Piselli P, Ippolito G.
BMC Infect Dis. 2013 May
14;13(1):217
Paper
FULL-TEXT
ARTICLE
The Cost and Impact of Scaling Up Pre-exposure Prophylaxis
for HIV Prevention: A Systematic Review of
Cost-Effectiveness Modelling Studies.
Gomez GB, Borquez A, Case KK,
et al
PLoS Med. 2013
Mar;10(3):e1001401
Paper
HIV PrEP Trials: The Road to Success.
Nicol MR, Adams JL, Kashuba AD.
Clin Investig (Lond). 2013 Mar;3(3).
Abstract
A Pill for HIV Prevention: Deja Vu All Over
Again?
Myers JE, Sepkowitz KA.
Clin Infect Dis.
2013 Feb 13.
Abstract |
Estimating the Efficacy of Preexposure
Prophylaxis for HIV Prevention Among Participants With a
Threshold Level of Drug Concentration.
Dai JY, Gilbert PB, Hughes JP, Brown ER.
Am J Epidemiol. 2013
Jan 9
Abstract
Antiretroviral Preexposure Prophylaxis for
HIV Prevention.
[No authors listed]
N Engl J Med.
2013 Jan 3;368(1):82-4 |
Abstract
|
Antiretroviral Preexposure Prophylaxis for HIV Prevention.
Bolland MJ, Grey A.
N Engl J Med.
2013 Jan 3;368(1):82-4.
Abstract
Antiretroviral Preexposure Prophylaxis for
HIV Prevention.
Kenyon C, Colebunders R.
N Engl J Med. 2013
Jan 3;368(1):82-4
Abstract |
The promise of pre-exposure prophylaxis with
antiretroviral drugs to prevent HIV transmission: a review.
Hankins CA, Dybul MR
Curr Opin HIV AIDS.
2012 Nov 29.
Abstract
Pre-exposure prophylaxis: where are we in
Europe?
Molina J.
J Int AIDS Soc. 2012
Nov 11;15(6):
Abstract
Are we PREPared? Quality of information available to patients in
the UK about PREP on the internet.
Duncan S, Duncan C.
J Int AIDS Soc. 2012 Nov 11;15(6):18167.
Abstract
Pharmacists as providers of HIV pre-exposure prophylaxis.
Bruno C, Saberi P.
Int J Clin Pharm. 2012 Oct 17.
Abstract
Engaging healthcare providers to implement
HIV pre-exposure prophylaxis.
Krakower D, Mayer KH
Curr Opin HIV AIDS.
2012 Oct 1.
Abstract
Oral antiretroviral chemoprophylaxis: current
status.
Baeten J, Celum C.
Curr Opin HIV AIDS. 2012 Sep 7
Abstract
FULL-TEXT ARTICLE
Interim
Guidance for Clinicians Considering the Use of Preexposure
Prophylaxis for the Prevention of HIV Infection in
Heterosexually Active Adults.
Centers for Disease Control and Prevention (CDC).
MMWR Morb Mortal Wkly Rep.
2012 Aug 10;61:586-9.
Paper
FULL-TEXT ARTICLE
A Qualitative Study of Provider Thoughts on Implementing
Pre-Exposure Prophylaxis (PrEP) in Clinical Settings
to
Prevent HIV Infection.
Arnold EA, Hazelton P, Lane T,
et al
PLoS One.
2012;7(7):e40603.
Paper
Preexposure Prophylaxis for HIV - Where Do We
Go from Here?
Cohen MS, Baden LR.
N Engl J Med.
2012 Jul 11.
Abstract
Antiretroviral Preexposure
Prophylaxis for Heterosexual HIV Transmission in Botswana.
Thigpen MC, Kebaabetswe PM, Paxton LA, et al
N Engl J Med.
2012 Jul 11.
Abstract
FULL-TEXT ARTICLE
The use of preexposure treatments for HIV prophylaxis.
Majid A, Redfield RR, Gilliam BL.
HIV AIDS (Auckl). 2012;4:17-28.
.
Paper
FULL-TEXT ARTICLE
Views of policymakers, healthcare workers and NGOs on HIV
pre-exposure prophylaxis (PrEP): a
multinational qualitative study.
Wheelock A, Eisingerich AB, Gomez GB,
et a
BMJ Open. 2012 Jul 2;2(4).
Paper
FULL-TEXT ARTICLE
Willingness to Accept HIV Pre-Exposure Prophylaxis among
Chinese Men Who Have Sex with Men
Zhou F, Gao L, Li S, et al.
PLoS ONE
7(3):
e32329
Paper
HIV Prevention by Oral Preexposure
Prophylaxis.
Heneine W, Kashuba A.
Cold Spring Harb Perspect Med.
2012 Mar;2(3):a007419.
Abstract |
FULL-TEXT ARTICLE
The
use of preexposure treatments for HIV prophylaxis.
Majid A, Redfield RR, Gilliam BL.
HIV AIDS (Auckl).
2012;4:17-28. .
Paper |
FULL-TEXT
ARTICLE
Attitudes and Acceptance of Oral and Parenteral HIV Preexposure Prophylaxis
among
Potential User Groups: A Multinational Study.
Eisingerich AB, Wheelock A, Gomez GB, et al
PLoS One. 2012;7(1):e28238.
Paper
Pre-Exposure Prophylaxis and Antiretroviral Resistance: HIV
Prevention at a Cost?
Hurt CB, Eron JJ Jr, Cohen MS.
Clin Infect Dis. 2011 Oct 5
Abstract
FULL-TEXT ARTICLE
2011
HIV Pre-Exposure
Prophylaxis (PrEP)—A Quantitative Ethics Appraisal.
Kokolo MB, Fergusson
DA, Cameron DW, et
al
PLoS ONE
6(8): e22497.
Paper
FULL-TEXT ARTICLE
Factors Influencing the Emergence and Spread of HIV Drug
Resistance Arising from Rollout
of Antiretroviral
Pre-Exposure Prophylaxis (PrEP).
Abbas UL, Hood G, Wetzel AW, Mellors JW.
PLoS One.
2011 Apr 15;6(4):e18165
Paper
A US Policy Perspective on Oral Preexposure Prophylaxis for HIV.
Leibowitz A, Parker K, Rotheram-Borus M.
Am J Public Health. 2011 Apr 14
Abstract
Pre-Exposure Prophylaxis and the Promise of
Combination Prevention Approaches.
Buchbinder SP, Liu A.
AIDS Behav. 2011 Feb
18.
Abstract |
Oral Preexposure Anti-HIV Prophylaxis for High-Risk U.S.
Populations: Current
Considerations in Light
of New Findings.
Myers GM, Mayer KH.
AIDS Patient Care STDS. 2011
Feb;25(2):63-71.
Abstract
FULL-TEXT
ARTICLE
Oral Preexposure Prophylaxis for HIV - Another
Arrow in the Quiver?
Michael NL.
N Engl J Med.
2010 Nov 23
Paper
|
FULL-TEXT ARTICLE
Evaluating the Cost-Effectiveness of Pre-Exposure Prophylaxis
(PrEP) and Its Impact on
HIV-1 Transmission in South Africa.
Pretorius C, Stover J, Bollinger L, Bacaër N, Williams B.
PLoS One.
2010 Nov 5;5(11):e13646.
Paper |
The risk of HIV drug resistance following
implementation of pre-exposure prophylaxis.
van de Vijver DA, Boucher CA.
Curr Opin Infect Dis.
2010 Sep 16.
Abstract
Packaging PrEP to Prevent HIV: An Integrated Framework to Plan for
Pre-Exposure Prophylaxis
Implementation in Clinical Practice
Underhill K, Operario D, Skeer M,
et al
J Acquir Immune Defic Syndr.
2010 Sep;55(1):8-13
Abstract
|
Pre-exposure Prophylaxis State of the Science: Empirical
Analogies for Research and Implementation.
Golub SA, Operario D, Gorbach PM
Curr HIV/AIDS Rep.
2010 Sep 1.
Abstract |
Planning for pre-exposure prophylaxis to prevent HIV
transmission:
challenges and opportunities.
Kim SC, Becker S, Dieffenbach C,
et al
J Int AIDS Soc.
2010 Jul 12;13(1):24
Abstract |
HIV, transmitted drug resistance, and the paradox of preexposure
prophylaxis.
Supervie V, García-Lerma JG, Heneine W, Blower S.
Proc Natl Acad Sci U S A.
2010 Jul 6;107(27):12381-6
Abstract |
General
Reports
Special
Populations
Drugs